Business Context and Reporting Period
This Form 8-K is filed by Owl Rock Capital Corporation (ORCC), an emerging growth company, with a report date of November 22, 2019. The filing details material definitive agreements entered into by two of the Company's subsidiaries, ORCC Financing IV LLC and ORCC Financing II LLC, regarding amendments to their respective secured credit facilities.
Key Financial Metrics and Debt Structure
The filing focuses on debt capacity adjustments rather than operational financial performance metrics such as revenue or profit.
- Financing IV Secured Credit Facility: The maximum principal amount was increased from $250 million to $450 million. This increase is to be implemented in periodic increments through March 22, 2020.
- Financing II Secured Credit Facility: The total revolving commitment was decreased from $400 million to $200 million.
- Liquidity and Availability: Availability for the Financing IV facility is subject to an overcollateralization ratio test, interest coverage ratio test, concentration limits, and collateral quality tests. The Financing II facility availability remains subject to similar conditions as prior to the amendment.
Material Changes Versus Prior Period
The primary material changes involve the restructuring of credit lines:
- Expansion of Capacity: ORCC Financing IV secured an amendment to increase its borrowing capacity by $200 million (an 80% increase from the previous $250 million limit).
- Reduction of Commitment: ORCC Financing II reduced its lender commitment by $200 million (a 50% reduction from the previous $400 million limit).
- Operational Flexibility: The Financing II amendment explicitly permits the subsidiary to draw on the facility and distribute funds to the parent company, subject to certain conditions.
Guidance, Outlook, and Risks
The filing does not provide forward-looking guidance, revenue outlook, or management commentary regarding future earnings. However, it highlights specific contingencies and risks associated with the debt facilities:
- Covenant Compliance: Access to the increased funds under Financing IV is contingent upon satisfying strict financial tests, including overcollateralization and interest coverage ratios.
- Collateral Quality: The availability of funds is tied to the value and quality of the assets held by the subsidiaries.
- Concentration Limits: The credit agreements include specific concentration limits that must be maintained.
Important Facts for Investor Verification
- Verify the current status of the overcollateralization and interest coverage ratios to determine if the full $450 million increase for Financing IV is immediately available.
- Confirm the specific assets pledged as collateral for both Financing II and Financing IV to assess the quality of the underlying security.
- Review the "periodic increments" schedule for the Financing IV increase to understand the timeline for accessing the additional $200 million.
- Examine the specific conditions under which ORCC Financing II can distribute funds to the parent company to evaluate potential liquidity impacts on the consolidated entity.